News Industry News Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair September 14, 2015
News Industry News Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter September 14, 2015
News Industry News Bristol-Myers Squibb and Pfizer Enroll First Patient in Phase 4 AUGUSTUS Trial to Evaluate Safety of Eliquis (apixaban) in Nonvalvular Atrial Fibrillation Patients with a Recent ACS or Undrgoing PCI September 09, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015
News Industry News Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study September 01, 2015
News Industry News Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor August 31, 2015
News Industry News LEADLESS II Trial Results Published in The New England Journal of Medicine Confirm the Positive Benefits of the Nanostim Leadless Pacemaker August 31, 2015
News Industry News FDA approves Repatha to treat certain patients with high cholesterol August 28, 2015
News Industry News BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure August 27, 2015
News Industry News Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions August 24, 2015
News Industry News New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology August 20, 2015
News Industry News Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events August 20, 2015
News Industry News Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System August 19, 2015
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015
News Industry News HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial August 10, 2015
News Industry News AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database August 06, 2015